Table 5.
Risk factors and drug therapy | Group 1a (n=46) | Group 1b (n=54) | Control group (n=50) | P value | |
Male gender | n | 32 | 37 | 29 | 0.06 |
% | 69.9 | 68.5 | 58.0 | ||
Smoking | n | 31 | 30 | 22 | 0.4 |
% | 67.4 | 55.6 | 44.0 | ||
Hypertension | n | 27 | 20 | 0 | 0.4 |
% | 57.8 | 37.9 | 0.0 | ||
Obesity (BMI >30 kg/m²) | n | 36 | 32 | 30 | 0.126 |
% | 78.3 | 59.3 | 60 | ||
Aspirin | n | 25 | 10 | 0 | 0.2 |
% | 54.3 | 18.5 | 0.0 | ||
Beta blocker | n | 40 | 8 | 3 | 0.6 |
% | 87.0 | 14.8 | 6.0 | ||
ACEI | n | 38 | 12 | 8 | 0.7 |
% | 82.6 | 22.2 | 16.0 | ||
Statin | n | 33 | 39 | 8 | 0.9 |
% | 71.7 | 72.2 | 16.0 | ||
Diuretics | n | 19 | 1 | 0 | 0.11 |
% | 41.3 | 1.9 | 0.0 |
ACEI, ACE inhibitor; BMI, body mass index.